Links to 3 New Hepatitis C Articles

[Guest guest]

Study Backs HCV Screens for All Boomers

CHICAGO -- Screening all baby boomers for hepatitis C virus (HCV) infection

could save tens of thousands of lives at a very acceptable cost, a researcher

said here.

http://www.medpagetoday.com/MeetingCoverage/DDW/26419

New HCV Drugs Expected to Be ’Breakthrough’

CHICAGO -- With two hepatitis C virus (HCV) protease inhibitors expected to win

FDA approval later this month, the hepatology community is looking at a genuine

breakthrough in treating HCV infections, a well-known researcher said in this

exclusive Infocus video report.

http://www.medpagetoday.com/MeetingCoverage/DDW/26404

Liver Disease: Identifying and Improving Screening and Treatment

CHICAGO -- This exclusive broadcast focuses on screening for hepatitis C based

on age instead of conventional risk factors and the rate of vaccination against

viral hepatitis in patients with chronic liver disease and type 2.

http://www.medpagetoday.com/MeetingCoverage/DDW/26290

[Guest guest]

Study Backs HCV Screens for All Boomers

CHICAGO -- Screening all baby boomers for hepatitis C virus (HCV) infection

could save tens of thousands of lives at a very acceptable cost, a researcher

said here.

http://www.medpagetoday.com/MeetingCoverage/DDW/26419

New HCV Drugs Expected to Be ’Breakthrough’

CHICAGO -- With two hepatitis C virus (HCV) protease inhibitors expected to win

FDA approval later this month, the hepatology community is looking at a genuine

breakthrough in treating HCV infections, a well-known researcher said in this

exclusive Infocus video report.

http://www.medpagetoday.com/MeetingCoverage/DDW/26404

Liver Disease: Identifying and Improving Screening and Treatment

CHICAGO -- This exclusive broadcast focuses on screening for hepatitis C based

on age instead of conventional risk factors and the rate of vaccination against

viral hepatitis in patients with chronic liver disease and type 2.

http://www.medpagetoday.com/MeetingCoverage/DDW/26290